Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Clinical Therapeutics
|
February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19
Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications
|
November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature
|
November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Nature Communications
|
October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Jens Bauer, Natalie Köhler, Yacine Maringer, et al.
Blood Cancer Discovery
|
October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
Annika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
The Lancet. Haematology
|
January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study
Jonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Nature Communications
|
February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Matthias Becker, Monika Strengert, Daniel Junker, et al.
Nature Immunology
|
October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Annika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Clinical Therapeutics
|
February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19
Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications
|
November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature
|
November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Nature Communications
|
October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Jens Bauer, Natalie Köhler, Yacine Maringer, et al.
Blood Cancer Discovery
|
October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
Annika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
The Lancet. Haematology
|
January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study
Jonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Nature Communications
|
February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Matthias Becker, Monika Strengert, Daniel Junker, et al.
Nature Immunology
|
October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Annika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Page
of 8